Nov 29, 2022 / 05:10PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this afternoon. A pleasure to have with us Avantor. We have the CEO, Michael Stubblefield, with us this afternoon.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics TeamMichael, when I look at life sciences 3Q, it's been a lot of moving parts there have been, whether it was some stocking dynamics in bioprocessing or macro, et cetera, and different companies have said different things, right? And I think for you guys specifically, you had a guidance change on the core. Maybe let's start with like a big picture question, right? I think if I just keep it very simple, other tools companies did not take their core down, Avantor took the core down. Is the share lost for Avantor? And how would you